Stockreport

BRIEF-Arbutus’ LNP licensee Alnylam initiates rolling submission of NDA for Patisiran [Reuters]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF BRIEF-Arbutus’ LNP licensee Alnylam initiates rolling submission of NDA for Patisiran | Reuters Reuters Staff 1 Min Read Nov 16 (Reuters) - Arbutus Biopharma Corp: * Arb [Read more]